Judgment of the Court (Sixth Chamber) of 3 March 2016
Teva Pharma BV and Teva Pharmaceuticals Europe BV v European Medicines Agency (EMA)
Appeal — Orphan medicinal products — Regulation (EC) No 141/2000 — Regulation (EC) No 847/2000 — Refusal to grant marketing authorisation for the generic version of the orphan medicinal product ‘imatinib mesylate’
Case C-138/15 P
published in the electronic Reports of Cases (Court Reports - general - 'Information on unpublished decisions' section)